Acute antipsychotic-induced akathisia revisited

被引：47
|
作者：
Poyurovsky, Michael [1 ]
机构：
[1] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
来源：
BRITISH JOURNAL OF PSYCHIATRY | 2010年 / 196卷 / 02期
关键词：
DOUBLE-BLIND; 2ND-GENERATION ANTIPSYCHOTICS; SCHIZOPHRENIA; DISORDERS; TRIAL; DRUGS;
D O I：
10.1192/bjp.bp.109.070540
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Akathisia remains one of the most prevalent and distressful antipsychotic-induced adverse events. Effective and well-tolerated treatment is a major unmet need in akathisia that merits a search for new remedies. Accumulating evidence indicates that agents with marked serotonin-2A receptor antagonism may represent a new class of potential anti-akathisia treatment.
引用
收藏
页码：89 / 91
页数：3
相关论文
共 50 条
  • [31] Management of acute antipsychotic-induced extrapyramidal syndromes
    Remington, G
    BezchlibnykButler, K
    CNS DRUGS, 1996, 5 : 21 - 35
  • [32] Mirtazapine for antipsychotic-induced acute akathisia: a systematic review and meta-analysis of randomized placebo-controlled trials
    Praharaj, Samir Kumar
    Kongasseri, Sreejayan
    Behere, Rishikesh V.
    Sharma, Podila Satya Venkata Narasimha
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2015, 5 (05) : 307 - 313
  • [33] Connection between the constitutional-morphological markers and the risk of antipsychotic-induced akathisia in patients with schizophrenia
    Goncharova, A.
    Kornetova, E.
    Dmitrieva, E.
    Kornetov, A.
    EUROPEAN PSYCHIATRY, 2020, 63 : S241 - S241
  • [34] Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor Antagonists
    Michael Poyurovsky
    Abraham Weizman
    Drugs, 2020, 80 : 871 - 882
  • [35] Antipsychotic-induced hyperprolactinemia
    Khouadja, S.
    Ben Soussia, R.
    Bouallagui, A.
    Marrag, I.
    Younes, S.
    Nasr, M.
    EUROPEAN PSYCHIATRY, 2017, 41 : S701 - S701
  • [36] Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor Antagonists
    Poyurovsky, Michael
    Weizman, Abraham
    DRUGS, 2020, 80 (09) : 871 - 882
  • [37] Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia A Systematic Review and Network Meta-Analysis
    Gerolymos, Cyril
    Barazer, Romain
    Yon, Dong Keon
    Loundou, Anderson
    Boyer, Laurent
    Fond, Guillaume
    JAMA NETWORK OPEN, 2024, 7 (03) : E241527
  • [38] Antipsychotic-induced hyperprolactinemia during acute treatment with antipsychotics
    Lee, BH
    Han, CS
    Kim, YK
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S283 - S283
  • [39] Antipsychotic-Induced Hyperprolactinemia
    Bostwick, Jolene R.
    Guthrie, Sally K.
    Ellingrod, Vicki L.
    PHARMACOTHERAPY, 2009, 29 (01): : 64 - 73
  • [40] Antipsychotic-induced hyperprolactinaemia
    Inder, Warrick J.
    Castle, David
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 (10): : 830 - 837
12345